What is Hemex?
HEMEX is dedicated to advancing the future of healthcare by providing comprehensive support to promising European startups. The company focuses on guiding innovators through every stage of development, from initial concept to market launch, for pharmaceuticals, medical devices, and in vitro diagnostics. Strategically located near the Basel Life Sciences hub, HEMEX offers startups access to tailored products, practical solutions, and crucial fundraising support, positioning itself as a key enabler of innovation in the life sciences.
How much funding has Hemex raised?
Hemex has raised a total of $7.6M across 1 funding round:
Series C
$7.6M
Series C (2021): $7.6M, investors not publicly disclosed
What's next for Hemex?
With a major enterprise-level funding context and a recent strategic investment, Hemex is poised for significant scaling and expansion. This capital infusion is expected to accelerate its mission of bringing groundbreaking healthcare solutions to market. The company's focus on guiding startups through development and fundraising suggests a strategy aimed at solidifying its role as a vital accelerator within the European biotech and medtech ecosystem. Future growth will likely involve expanding its network of supported startups and deepening its service offerings.
See full Hemex company page
